STRATEGIC INVESTMENT MANAGEMENT, LLC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 141 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
STRATEGIC INVESTMENT MANAGEMENT, LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2016$45,00011,3170.03%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2016
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders